Mike Gorenstein

Cannabis company Cronos Group Inc (NASDAQ: CRON) plans on launching vaping devices in Canada with a focus on safety, quality and proper ingredients, company founder and CEO Mike Gorenstein told CNBC's Jim Cramer. What Happened Cronos opened a cannabinoid device R&D facility in Israel...

Shares of Cronos Group Inc (NASDAQ: CRON) traded higher Thursday morning after the cannabis company reported a four-fold jump in revenue year-over-year in its second quarter results. Cronos said it earned 22 cents per share in the second quarter on revenue of CA$10.237 million. By comparison, the...

Cronos Group (NASDAQ: CRON) on Tuesday announced the appointment of Dr. Todd Abraham as the company's Chief Innovation Officer. Abraham "will be responsible for advancing Cronos Group’s research and development initiatives in cannabinoids with a focus on identifying new disruptive...

MediPharm Labs Corp. (TSXV: LABS)(OTC: MEDIF) has agreed to a multi-year supply deal with Cronos Group Inc. (NASDAQ: CRON). What To Know Per the deal, MediPharm will supply Cronos Group's wholly-owned subsidiary, Peace Naturals Project Inc., with roughly $30 million in cannabis concentrate over...

Shares of Cronos Group Inc (NASDAQ: CRON) soared 25 percent Friday morning after the Canada-based cannabis company confirmed it received a C$2.4 billion ($1.8 billion) investment from cigarette company Altria Group Inc (NYSE: MO). Rumors of a potential acquisition between the two companies were...